These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33919841)

  • 21. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
    Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
    Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats.
    Siragy HM; Inagami T; Carey RM
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1461-7. PubMed ID: 17670863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling.
    Bhushan S; Kondo K; Polhemus DJ; Otsuka H; Nicholson CK; Tao YX; Huang H; Georgiopoulou VV; Murohara T; Calvert JW; Butler J; Lefer DJ
    Circ Res; 2014 Apr; 114(8):1281-91. PubMed ID: 24599803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study.
    Rosenbaek JB; Pedersen EB; Bech JN
    BMC Nephrol; 2018 Sep; 19(1):244. PubMed ID: 30241504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction.
    Clavell AL; Stingo AJ; Aarhus LL; Burnett JC
    Am J Physiol; 1993 Dec; 265(6 Pt 2):R1416-22. PubMed ID: 8285286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions.
    Bozkurt B; Nair AP; Misra A; Scott CZ; Mahar JH; Fedson S
    JACC Basic Transl Sci; 2023 Jan; 8(1):88-105. PubMed ID: 36777165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
    Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
    Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
    Bishu K; Deswal A; Chen HH; LeWinter MM; Lewis GD; Semigran MJ; Borlaug BA; McNulty S; Hernandez AF; Braunwald E; Redfield MM
    Am Heart J; 2012 Nov; 164(5):763-770.e3. PubMed ID: 23137508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
    Bodiga S; Zhong JC; Wang W; Basu R; Lo J; Liu GC; Guo D; Holland SM; Scholey JW; Penninger JM; Kassiri Z; Oudit GY
    Cardiovasc Res; 2011 Jul; 91(1):151-61. PubMed ID: 21285291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
    Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
    Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
    Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
    Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.
    Yang J; Chen C; Ren H; Han Y; He D; Zhou L; Hopfer U; Jose PA; Zeng C
    J Hypertens; 2012 Jun; 30(6):1176-84. PubMed ID: 22504846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.
    de Vries LV; Dobrowolski LC; van den Bosch JJ; Riphagen IJ; Krediet CT; Bemelman FJ; Bakker SJ; Navis G
    Am J Kidney Dis; 2016 Jun; 67(6):936-44. PubMed ID: 26803690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
    Ali Q; Dhande I; Samuel P; Hussain T
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
    Díez J
    Eur J Heart Fail; 2017 Feb; 19(2):167-176. PubMed ID: 27766748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
    Bae EH; Ma SK; Lee J; Kim SW
    Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
    Patel VB; Lezutekong JN; Chen X; Oudit GY
    Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
    Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
    Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.